THROMBOSIS AND HEMOSTASIS Structural basis for catalytic activation of protein Z–dependent protease inhibitor (ZPI) by protein Z

نویسندگان

  • Xin Huang
  • Yahui Yan
  • Yizheng Tu
  • Jeffrey Gatti
  • George J. Broze
  • Aiwu Zhou
  • Steven T. Olson
چکیده

The anticoagulant serpin, protein Z-dependent protease inhibitor (ZPI), is catalytically activated by its cofactor, protein Z (PZ), to regulate the function of blood coagulation factor Xa on membrane surfaces. The X-ray structure of the ZPI-PZ complex has shown that PZ binds to a unique site on ZPI centered on helix G. In the present study, we show by Ala-scanning mutagenesis of the ZPIbinding interface, together with native PAGE and kinetic analyses of PZ binding to ZPI, that Tyr240 and Asp293 of ZPI are crucial hot spots for PZ binding. Complementary studies with protein Z–protein C chimeras show the importance of both pseudocatalytic and EGF2 domains of PZ for the critical ZPI interactions. To understand how PZ acts catalytically, we analyzed the interaction of reactive loop– cleaved ZPI (cZPI) with PZ and determined the cZPI X-ray structure. The cZPI structure revealed changes in helices A and G of the PZ-binding site relative to native ZPI that rationalized an observed 6-fold loss in PZ affinity and PZ catalytic action. These findings identify the key determinants of catalytic activation of ZPI by PZ and suggest novel strategies for ameliorating hemophilic states through drugs that disrupt the ZPI-PZ interaction. (Blood. 2012;120(8):1726-1733)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY A nonsense polymorphism in the protein Z–dependent protease inhibitor increases the risk for venous thrombosis

The protein Z–dependent protease inhibitor (ZPI) is a hemostatic serpin with anticoagulant activity. As for antithrombin, deficiency of ZPI could have relevant thrombotic consequences. We have studied 6 genetic modifications affecting the ZPI gene, identifying 5 haplotypes. Haplotype H5 is featured by a stop codon at position 67. The relevance of these genetic modifications and haplotypes in ve...

متن کامل

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Characterization of the protein Z–dependent protease inhibitor

Protein Z-dependent protease inhibitor (ZPI) is a 72-kd member of the serpin superfamily of proteinase inhibitors that produces rapid inhibition of factor Xa in the presence of protein Z (PZ), procoagulant phospholipids, and Ca11 (t1/2 less than 10 seconds). The rate of factor Xa inhibition by ZPI is reduced more than 1000-fold in the absence of PZ. The factor Xa–ZPI complex is not stable to so...

متن کامل

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo

Tissue factor pathway inhibitor (TFPI) plays a key role in the regulation of tissue factor-initiated blood coagulation secondary to loss of the integrity of the blood vessel wall. TFPI is a naturally occurring Kunitz-type protease inhibitor that inhibits coagulation factor Xa and, in a factor Xa-dependent manner, mediates feedback inhibition of the factor VIIa/tissuefactor catalytic complex. In...

متن کامل

The Role of Cofactors and the Endothelial Cell Surface in Protein-c Activation

ANTICOAGULANT PATHWAY P ROTEIN-C is a vitamin-K-dependent plasma zymogen.’ After activation, activated protein-C differs from the vitamin-K-dependent plasma clotting factors in that it potently inhibits coagulation5 by inactivating factors V6’7 and VIII,7’8 and it facilitates fibrinolysis in vivo9”#{176} by elevating circulating plasminogen activator levels.tO Clinical evidence of protein-C inv...

متن کامل

Protein-C: biochemistry, physiology, and clinical implications.

ANTICOAGULANT PATHWAY P ROTEIN-C is a vitamin-K-dependent plasma zymogen.’ After activation, activated protein-C differs from the vitamin-K-dependent plasma clotting factors in that it potently inhibits coagulation5 by inactivating factors V6’7 and VIII,7’8 and it facilitates fibrinolysis in vivo9”#{176} by elevating circulating plasminogen activator levels.tO Clinical evidence of protein-C inv...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2012